| abstract |
The present invention relates to an antibody drug conjugate (ADC) of general formula (I) (D-Lk<sub>1</sub>-C(O)-Lk<sub>2</sub>-C<sub>2</sub>H<sub>4</sub>-NH-Lk<sub>3</sub>)<sub>n</sub>-Ab. A pharmaceutical composition comprising, in a pharmaceutically acceptable medium, the said ADC is also concerned by the present invention, as well as the use of this ADC or composition as a medicament, and in particular in the prevention and/or the treatment of an anti-Müllerian hormone type II receptor (AMHRII) expressing cancer in an individual. |